Compare · MO vs PXMD
MO vs PXMD
Side-by-side comparison of Altria Group Inc. (MO) and PaxMedica Inc. (PXMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MO and PXMD operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- MO carries a market cap of $92.73B.
- Over the past year, MO is up 15.0% and PXMD is up 0.0% - MO leads by 15.0 points.
- MO has hit the wire 1 time in the past 4 weeks while PXMD has been quiet.
- MO has more recent analyst coverage (19 ratings vs 0 for PXMD).
- Company
- Altria Group Inc.
- PaxMedica Inc.
- Price
- $66.89-0.41%
- $0.72-3.73%
- Market cap
- $92.73B
- -
- 1M return
- +4.85%
- +0.00%
- 1Y return
- +14.95%
- +0.00%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- News (4w)
- 1
- 0
- Recent ratings
- 19
- 0
Altria Group Inc.
Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, oral tobacco products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in transportation, power generation, real estate, and manufacturing equipment industries. The company sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
Latest MO
- Altria to Host Webcast of 2026 First-Quarter Results
- SEC Form DEFA14A filed by Altria Group Inc.
- SEC Form DEF 14A filed by Altria Group Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Altria Group Inc.
- on! PLUS™ Expands Nationwide Retail Availability
- SVP, Chief HR Off. & CCO Whitaker Charles N. sold $1,885,718 worth of shares (27,908 units at $67.57), decreasing direct ownership by 13% to 180,869 units (SEC Form 4)
- EVP & General Counsel Mccarter Robert A. Iii was granted 5,767 shares and covered exercise/tax liability with 4,517 shares, increasing direct ownership by 1% to 123,612 units (SEC Form 4)
- Chief Executive Officer Gifford William F. Jr. was granted 70,364 shares and covered exercise/tax liability with 61,849 shares, increasing direct ownership by 1% to 681,942 units (SEC Form 4)
- EVP & CFO Mancuso Salvatore was granted 17,166 shares and covered exercise/tax liability with 17,385 shares, decreasing direct ownership by 0.08% to 280,275 units (SEC Form 4)
- Vice President and Controller Patterson Katie F covered exercise/tax liability with 844 shares, decreasing direct ownership by 5% to 17,513 units (SEC Form 4)
Latest PXMD
- PaxMedica Inc. filed SEC Form 8-K: Leadership Update
- PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions
- Amendment: SEC Form SC 13G/A filed by PaxMedica Inc.
- SEC Form NT 10-Q filed by PaxMedica Inc.
- SEC Form EFFECT filed by PaxMedica Inc.
- SEC Form S-1 filed by PaxMedica Inc.
- SEC Form 10-Q filed by PaxMedica Inc.
- PaxMedica Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits
- PaxMedica Secures Immediate Exercise of Warrants
- PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection